Condition
Helicobacter Gastritis
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown3
Clinical Trials (3)
Showing 3 of 3 trials
NCT04029441UnknownPrimary
The Effact of Helicobacter Hylori Eradication on the Development of Gastric Mucosa Pathology
NCT03802318Not ApplicableUnknown
Daily Four Times or Two Times Usage of PPI and Amoxicillin for the First or Second Line H. Pylori Eradication
NCT00275886UnknownPrimary
Activation and Recruitment of GIL During Hp Infection
Showing all 3 trials